
Director, Englander Institute for Precision Medicine @WCMenglanderIPM, Associate Director @wcmc_ctsc & ICB, Co-Founder @volastratx & @onethreebiotech
New York city
Joined January 2012
- Tweets26.7K
- Following952
- Followers6.2K
- Likes16.3K
Big news today: I am deeply honored to receive the NIH Director's Pioneer Award, one of only seven given this year across all fields! We will build an AI engine that generates cancer hypotheses from human data and tests them with robots in tumor organoids news.weill.cornell.edu/news/…
1/ 🎬 You can now turn a paper into beautiful slides—then into a narrated video presentation—all using AI.
I just did it with our new NEJM AI paper (led by @narges_razavian ). 5 minutes for the full video, 15 slides, narration synced to each one. Here's how 🧵
🎓 Medical students: AI is transforming medicine. EIPM was at Weill Cornell's Area of Concentration fair—we have projects in deep learning on pathology images, genomics/proteomics, and multi-agent AI systems. All levels welcome. Reach out to apply AI to real patient problems.
Beyond Mundane AI: A Path to Cultivating Superusers open.substack.com/pub/profel…
1/6 I’ve always loved the promise of AR: to bring us closer to our data. But clunky interaction often gets in the way.
My hypothesis is that voice may be the key to finally achieving that fluid connection. I built this prototype on the Apple Vision Pro to test it. Here's a demo:
AI is challenging the paradigm of "undruggable" cancer targets. Our new Nature Biotechnology comment outlines how AI-driven approaches, from modeling protein complexes to designing novel biologics, can unlock these intractable proteins nature.com/articles/s41587-0…
From Clinic to Code: A Strategic AI Checklist open.substack.com/pub/profel…
AI Governance: The Accelerator, Not the Anchor open.substack.com/pub/profel…
A New Pharma World Order: The Inevitable Rise of Chinese Drug Innovation open.substack.com/pub/profel…









